QIAGEN N.V. (NASDAQ:QGEN)
CAPS Rating:
The Company is a provider of innovative technologies and products for preanalytical sample preparation and linked molecular assay solutions.
For investors, by investors
The Company is a provider of innovative technologies and products for preanalytical sample preparation and linked molecular assay solutions.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
exposure to RNAi, better valuation than Alnylam Pharmaceuticals Inc. (ALNY)